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Abstract 
 
The whey protein separation potential of aqueous two-phase systems of arabinogalactan [AG] 
(Lonza FiberAidTM) and polyethylene glycol [PEG], buffered with 10 mmol/g phosphate or citrate 
buffer, was studied.  100 mmol/g potassium chloride [KCl] was added as required.  Previously-
published phase equilibrium results were verified and the absorbance of whey protein isolate [WPI] 
in an AG-PEG solution was measured. The effect of pH, KCl concentration, initial WPI concentrations 
and upper to lower phase mass ratios on whey partitioning was studied. The best separation system 
contained 17.20% (w/w) AG, 7.20% (w/w) PEG, 10 mmol citrate buffer (pH 5.4) and 100 mmol KCl 
per gram of total system. The upper to lower phase mass and volume ratios were 1:1 and 16:11 
respectively. Approximately 12 mg (mainly α-lactalbumin) of the 20 mg WPI added partitioned into 
the AG-rich upper phase.  This system has potential to reduce chromatographic requirements in 
large scale separation of protein mixtures. 
Keywords: two-phase aqueous extraction; whey; arabinogalactan; polyethylene glycol 
Introduction 
 
Biopharmaceutical production is a rapidly growing industry, and is likely be worth approximately 1.3 
trillion USD by 2020 (Rosa et al., 2010). Monoclonal antibodies are an important growth area in the 
biopharmaceutical industry, and are now estimated to be worth 50 billion USD per annum (Rosa, et 
al., 2010). Other growth areas include therapeutic recombinant proteins and nucleic acid based 
medical products. They are all highly effective in their applications, which include treating 
cardiovascular disease, cancer, autoimmune disorders, inflammatory problems, neurological 
problems, as well as being used for vaccination purposes (Rosa, et al., 2010). 
 
Unfortunately the cost of producing many biopharmaceuticals remains a barrier to their widespread 
use. For example, the cost of a monoclonal antibody treatment can be up to 40 thousand USD per 
patient (Rosa, et al., 2010). Downstream processing costs make up approximately 80% of the total 
production cost of many biopharmaceuticals, and purification costs make up approximately 70% of 
the downstream processing costs (Azevedo et al., 2009a; Rosa, et al., 2010). 
 
 
1319 CHEMECA 2014: Sept 28 – Oct 01 2014, Perth, Western Australia 
The relatively high downstream processing costs in biopharmaceutical production are largely due to 
the reliance on packed bed chromatography at the purification step. Although a mature technology, 
increases in packed bed chromatography yields have not kept pace with increases in upstream 
process yields. Hence the cost of packed bed chromatography has increased relative to upstream 
processing costs (Rosa, et al., 2010). Furthermore, packed bed chromatography technology has a low 
throughput, high residence time, requires expensive media and is limited to batch operation 
(Azevedo, et al., 2009a; Rosa, et al., 2010). These all limit the potential for cost reduction. 
 
One way to reduce downstream processing costs is to reduce or eliminate the use of packed bed 
chromatography at the purification step. This can be done by using complementary technologies 
such as two-phase aqueous extraction systems. Examples include: using phosphate buffer and 
polyethylene glycol [PEG] (modified with glutaric acid) to extract monoclonal antibody IgG1 from 
Chinese hamster ovary (CHO) supernatant (Azevedo et al., 2009b); using PEG and maltodextrin to 
extract whey proteins (da Silva & Meirelles, 2000); and using citrate buffer, PEG and dextran to 
extract an extracellular lipase from Burkholderia pseudomallei (Ooi et al., 2011). 
 
The two-phase aqueous system formed by PEG and arabinogalactan [AG] was first investigated by 
(Christian et al., 1998) as an alternative to using a PEG-dextran system for separating bovine serum 
albumin. AG is approximately one fifteenth of the price of dextran (Azevedo, et al., 2009a; Christian, 
et al., 1998). Unlike maltodextrins and waxy starch from cashew nut tree gum, AG is not susceptible 
to attack by starch degrading enzymes (Christian, et al., 1998; Sarubbo et al., 2004). 
 
This study investigated the potential of an AG-PEG system to separate whey proteins (α-lactalbumin, 
β-lactoglobulin and bovine serum albumin (Goff, 2009)). Whey proteins are a mixture of proteins 
with different biochemical properties. Hence separating whey proteins is similar to separating a 
biopharmaceutical from a protein mixture (Seader et al., 2011). Unlike many biopharmaceuticals, 
whey proteins are also inexpensive and relatively easy to obtain 
 
Preliminary attempts were made to optimise system parameters such as pH, salt concentration, 
initial whey protein dose, and upper to lower phase mass ratio. The former two parameters affect 
the solubility and the hydrophobicity of the whey proteins (Garrett & Grisham, 2005); the latter two 
affect the driving force for mass transfer (Albertsson, 1986). All affect separation performance. 
Materials and Methods 
 
Larch arabinogalactan powder [AG] (Lonza FiberAidTM) was kindly supplied by Lonza Inc. (Allendale, 
NJ, USA); polyethylene glycol powder [PEG] (average Mw = 8000) was purchased from Dow Chemical 
(NZ) Ltd. (Auckland, New Zealand) and whey protein isolate [WPI] powder was purchased from 
Punch Supplements Ltd (Auckland, New Zealand). Note that the WPI to contain negligible bovine 
serum albumin (BSA). These powders were used in dry form and mixed with distilled water to 
prepare standard solutions: AG (40% w/w); PEG (20% w/w); WPI (20 mg/ml; 150 mg/ml). 
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α-lactalbumin (α-lac) and β-lactoglobulin (β-lac) were purchased from Sigma-Aldrich (Auckland, New 
Zealand) as lyophilised powders. They were mixed with distilled water to prepare standard protein 
solutions (5 mg/ml and 10 mg/ml, respectively). 
 
Stock solutions of citrate buffer (100 mM, pH 3.0; 100 mM, pH 5.4; 10 mM + 100 mM KCl, pH 5.4), 
phosphate buffer (100 mM, pH 7.4), potassium chloride [KCl] (1 M) and sodium hydroxide (1M) were 
prepared using laboratory dry stock chemicals. 1M NaOH was used to correct the pH of the buffers. 
Note that the quoted buffer strengths do not account for the minor changes in molarity caused by 
the pH correction. 
 
The densities of the stock solutions were determined by weighing a fixed volume of each solution. 
 
Turbidimetric titration 
The phase equilibrium curve of Christian, et al. (1998) was verified by the second turbidimetric 
titration method of Albertsson (1986). Specified masses of AG and PEG powder were added to a 50 
mL centrifuge tube; the system was then made up to a total mass of 25 g with distilled water. The 
centrifuge tube was then capped and vortex mixed at 2100 rpm for 30 s, creating a turbid 
suspension. Distilled water was added dropwise from a burette until the system became 
transparent. The volume of water added was recorded and the mass composition of the system was 
determined by mass balance. 
 
Tie line verification 
Polarimetry and turbidmetry were used to verify the phase-equilibrium tie lines obtained by 
Christian, et al. (1998). In both cases samples of AG-PEG two phase aqueous systems were prepared 
by adding known masses (based upon the X1-X2 tie line of Christian, et al. (1998)) of AG and PEG 
powder to a 50 mL centrifuge tube and adding distilled water to form a 30 g system. These solutions 
were then vortex mixed for 30 s at 2000 rpm and centrifuged at 2000 ECF for 5 minutes. 
 
Standard solutions of AG were prepared by adding known masses of AG to 15 mL centrifuge tubes 
and adding distilled water to form a 10 g system. The centrifuge tubes were then capped and vortex 
mixed at 2000 rpm for 30 s. 
 
All samples and standards were then equilibrated to 30°C in a serological water bath. A polarimeter 
(Na D lamp, 20-cm tubes) was used to record the optical rotation of the samples and compare them 
to the standards and specific optical rotation results obtained by Christian, et al. (1998). All samples 
and most standards proved too concentrated for the instrument, and a 100× dilution did not 
overcome the problem. Hence the polarimetric tie-line verification was abandoned. 
 
The samples and standards were re-equilibrated to 25°C in a serological water bath and turbidity 
measurements were taken using a Hach 2100P turbidimeter. The standards were used to graphically 
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correlate turbidity (Nephelometric Turbidity Units [NTU]) and AG concentration (wt %) and the 
results used to determine the AG content of the samples. The PEG concentration was determined 
from the phase equilibrium curve of Christian, et al. (1998). Note that the contribution of PEG to 
turbidity was assumed to be negligible. 
 
Standard curves of absorbance against whey protein concentration 
Preliminary spectrophotometric scans of α-lac and β-lac solutions (2 mg/ml protein in buffer) failed 
to find a unique wavelength for each protein, but confirmed that all whey proteins strongly absorb 
280 nm light. Absorbance measurements of blank top phases determined that AG strongly absorbed 
280 nm light. Hence all further measurements were carried out at 100x dilution. 
 
Simulated 100x dilute upper phases with a total mass of 5 g were created by adding calculated 
volumes of stock AG solution, PEG solution, WPI solution (20 mg/ml); buffer solution and KCl 
solution (where appropriate) to a 15 mL centrifuge tube. The centrifuge tubes were then capped and 
vortex mixed for 30 s at 2000 rpm. The concentrations of whey protein in each phase ranged from 
0.0 to 2.0 mg/ml. 
 
A Heλios® UV-Visible spectrophotometer was blanked against samples free of whey protein and 
used to measure the absorbance of each sample at 280 nm, and the results used to prepare a 
standard curve of absorbance and whey protein concentration. 
 
Whey Partitioning Experiments 
Two-phase aqueous systems with a total mass of 10 g were created by adding calculated volumes of 
stock AG solution, PEG solution, WPI solution (150 mg/ml); buffer solution and KCl solution (where 
appropriate) to a 15 mL centrifuge tube (Table 1). The resulting mass fractions of AG and PEG can be 
found in Table 2. These solutions were then vortex mixed for 30s at 2000 rpm and centrifuged at 
2000 ECF for 5 minutes. Each run was performed in triplicate. 
 
Following centrifugation, the volumes of the upper and lower phases were recorded. Samples of the 
top phase were taken and diluted 100× by volume. The absorbance of each dilute sample was then 
measured at 280 nm. Protein concentration was determined from the standard curve and the 
volume ratio was used to determine the partition coefficient (Kp): 
 
   
                                   
                                  
 
 
Table 1. Whey partitioning system properties 
Run pH KCl [mmol/ g solution] Upper : Lower Phase Mass Ratio WPI 
[mg WPI/g solution] 
1 3.0 0 1:1 20 
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2 3.0 100 1:1 20 
3 5.4 0 1:1 20 
4 5.4 100 1:1 20 
5 7.4 0 1:1 20 
6 7.4 100 1:1 20 
7 5.4 100 1:1 10 
8 5.4 100 3:1 20 
9 5.4 100 3:1 10 
 
Table 2. Whey partitioning system AG and PEG mass fractions 
Upper: Lower Phase Mass Ratio x(AG) (% w/w) x(PEG) (% w/w) 
1.0 17.80% 7.20% 
3.0 9.25% 10.50% 
 
Spectrophotometric arabinogalactan correction 
The original whey partitioning method assumed that the PEG-AG phase equilibrium was unaltered 
by the presence of salts and protein, limiting its accuracy. Preliminary scans indicated that whilst 
both AG and WPI absorbed 280 nm light, only AG absorbed 320 nm light. Hence standard curves of 
absorbance (280 nm; 320 nm) against AG concentration, and absorbance (280 nm) against WPI 
concentration were prepared. 
The best two runs (four and seven) from the original partitioning experiments were then repeated at 
13% of their original protein concentration, and a blank system (i.e. without WPI) was also prepared. 
These runs are summarised in Table 3. All runs were performed in triplicate. 320 nm absorbance 
readings were used to determine the AG concentration in the top phase. Hence 280 nm absorbance 
measurements were corrected for AG content by deducting an absorbance value determined from 
standard curve of 280 nm absorbance against AG concentration. 
An additional three triplicates of run ten (Table 3) were then tested for upper-phase and lower-
phase AG concentration using 320 nm absorbance readings. 
Table 3. Whey partioning systems verified by spectrophotometric methods 
Run Original 
Run 
pH KCl 
[mmol/ g 
solution] 
Upper : Lower Phase Mass 
Ratio 
WPI 
[mg WPI/g 
solution] 
10 – 5.4 100 1:1 0 
11 7 5.4 100 1:1 1.3 
12 4 5.4 100 1:1 2.7 
 
Fast protein liquid chromatography (FPLC) 
An upper phase sample (10x dilute) from run four of the whey partitioning experiments was run on 
an Äkta FPLC fitted with a Superdex 200 10/300 column in citrate buffer (10mM + 100 mM KCl, pH 
5.4). The sample volume was 50 μL and the flowrate was 0.5 ml/min. Samples of WPI (20 mg/ml), α-
lac (5 mg/ml); β-lac (10 mg/ml); AG (8% w/w) and PEG (20% w/w) were run under the same 
conditions. The mass ratio of α-lac to β-lac in the WPI was calculated using extinction coefficients of 
28540 M-1cm-1 and 17600 M-1cm-1, respectively (Engel, van Mierlo and Visser, 2002; Collini, D’Alfonso 
and Baldini, 2000). The molar masses used in the calculations were 14000 gmol-1 and 18400 gmol-1, 
respectively (Sigma-Aldrich, 2014). 
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Results and Discussion  
Turbidimetric Titration 
The results of the turbidimetric titration are summarised in Table 4. Note that each set contained 
three triplicates. The results for sets one and three agree with the published results of Christian, et 
al. (1998), but the results from set two indicate a lower than expected PEG concentration. This was 
probably due to the difficulty of determining the end point of the turbidimetric titration. Solutions 
rich in AG are a dark brown colour, and this makes it difficult to determine the precise point at which 
the turbid solution becomes clear. Future titrations should use the first turbidimetric titration 
method of Albertsson (1986), which adds PEG solution of a known concentration to a fixed volume 
of AG solution of known concentration until turbidity ensues. 
 
Table 4. Turbidimetric titration results 
Set xa(AG) (% w/w) xa(PEG) (% w/w) xa(H2O) (% w/w) Relative Uncertainty 
1 14.94 5.52 79.53 0.35% 
2 18.06 1.92 80.03 4.27% 
3 5.24 9.02 85.74 0.79% 
 
                    
                 
                  
 
 
Tie Line Verification 
The correlation between turbidity and arabinogalactan concentration (Figure 1) is approximated by a 
straight line when the solution contains less than 20% AG by mass. Above this concentration the 
curve approaches an asymptote of approximately 100 NTU. 
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Figure 1. Initial standard curve of turbidity against AG concentration (% w/w) 
 
The turbidity standards deteriorated rapidly with age, making it necessary to prepare fresh turbidity 
standards every day, although this was only done for AG concentrations of up to 10% by mass. The 
final plot used to verify the tie lines is shown in Figure 2. 
 
Figure 2. Final standard curve of turbidity against AG concentration (% w/w) 
 
In most cases, AG concentration of the top phases was found to be between 0.4% and 0.45% by 
mass, which is within the expected range (i.e. less than 1% AG w/w), but inconsistent with the 
predicted result (approximately 0.72% w/w). As the gradient of the curve was steep, this variation 
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could be easily explained by the error of the instrument (1 NTU). Using 280 nm absorbance 
measurements may be a more reliable method of determining AG concentration. 
 
Standard Curves of Absorbance and Whey Protein Concentration 
The calibration curves of absorbance and whey protein concentration (Figure 3) indicate that the 
spectrophotometer is best used for WPI concentrations less than 1 mg/ml, as the blank top phase 
absorbed approximately 25% of the 280 nm UV light emitted by the detector. 
 
Figure 3: Standard curves of 280 nm absorbance against WPI concentration. 
 
Whey Partitioning Experiments 
The top phases of systems 1, 2, 3, 5 and 6 had negligible absorbances, indicating all the WPI was still 
in the lower phase. System four and its optimisation, system seven had substantial absorbances in 
the top phase (>0.1), indicating that substantial protein separation had taken place (Table 5, Table 6 
Table 7). 
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System four exhibited a strong, but realistic recovery of WPI. It had an overall WPI partition 
coefficient of 1.50 and 60.0% recovery of WPI in the upper phase. This suggests that the WPI has a 
stronger affinity for the upper phase. Hence this system could potentially be used for commercial 
scale extraction of whey proteins or similar biological compounds. 
 
The results from system eight indicate that increasing the relative mass of the top phase greatly 
decreases protein recovery. However the effect of decreasing the relative mass of the upper phase is 
unknown. Hence the system containing: 17.20% (w/w) AG; 7.20% (w/w) PEG; 10 mmol/g citrate 
buffer (pH 5.4); 100.0 mmol/g KCl; and 20 mg/g of WPI worked well, but little optimisation has been 
carried out in this region. Future work should attempt to optimise these parameters, using the 
values used in this work as a starting point. 
 
The data from system seven is less conclusive, but suggest protein recovery can be enhanced by 
lowering the initial WPI dose. This is consistent with WPI precipitate being observed in the bottom 
phase of most AG-PEG systems. However the theoretical WPI recovery for this system exceeds 
100%, which is not realistic. 
 
Table 5. Absorbance measurements and upper phase protein concentrations for high-performing AG-PEG two-
phase aqueous extraction systems 
Run  Absorbance Dilution Factor Upper Phase Protein Concentration (mg/mL) 
4 0.220 0.01 22.6 
7 0.318 0.01 35.5 
 
Table 6. Volume ratios for high performing AG-PEG two-phase aqueous extraction systems 
Run  Upper Phase Volume (mL) Lower Phase Volume (mL) Total System Volume (mL) 
4 5.33 3.67 9.00 
7 5.30 3.37 8.67 
 
Table 7. Protein recovery parameters for high performing AG-PEG two-phase aqueous-extraction systems  
Run  Total WPI in 
System (mg) 
WPI in Upper 
Phase (mg) 
Upper Phase WPI 
Recovery (% w/w) 
 Overall WPI Partition 
Coefficient (Kp) 
4 201.0 121 60.0% 1.50 
7 101.4 188 185.5% -2.17 
 
The most likely cause of these high absorbance readings was the blank used to zero the 
spectrophotometer. All blanks in the experiments were simulated top phases made up with AG, PEG 
and distilled water to match the compositions found on the phase equilibrium diagram of Christian, 
et al. (1998). As AG absorbs 280 nm ultraviolet light, even a slight error in the phase composition 
could cause the protein concentration to be overestimated. This problem could potentially be 
overcome by spectrophotometric correction. 
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In general, all successful WPI separations were carried out at a pH 5.4, in the presence of 10 mmol/g 
KCl. Separations carried out at pH 3.0 or 7.4 or in the absence of KCl were unsuccessful, indicating 
that separation success is closely related to pH and salt concentration. 
 
The pH optimum could be explained by pH 5.4 being the experimental pH closest to the isoelectric 
point of whey proteins (5.0) (Goff, 2009). As the PEG-rich upper phase is more hydrophobic 
(Christian, et al., 1998), having a system pH close to the isoelectric point is likely to make the whey 
proteins more soluble in hydrophobic solutions by reducing the ionisation of amino acids (Garrett & 
Grisham, 2005). 
 
The presence of 100 mmol/g of KCl in the most effective separation systems is unremarkable, as it is 
well known that low concentrations of salt can enhance the solubility of proteins (Garrett & 
Grisham, 2005). However as KCl breaks down water structure (i.e. is a chaotropic salt), it favours 
protein migration to the hydrophobic phase (Rosa, et al., 2010).  It would be interesting to see how 
the use of a water structure-stabilising (i.e. kosomtropic) salt affects protein separation 
performance. 
 
Spectrophotometric arabinogalactan correction 
The standard curves for AG (Figure 4) and WPI (x-r) indicate a linear correlation between absorbance 
and concentration of AG and WPI. Hence 320 nm absorbance measurements can be used to correct 
280 nm absorbance measurements for AG absorbance, as AG does not absorb 320 nm light. 
 
Figure 4. Standard curve of absorbance at 280 nm and 320 nm against AG concentration (% w/w) 
 
The results of the partitioning experiments (Table 8 – Table 10) were inconclusive. The low initial 
concentration of WPI meant that the whey protein that migrated into the upper phase was barely 
detectable, and hence there was a large measurement error. The upper phase AG concentration was 
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also much higher than expected (< 1 wt%), and decreased in the presence of WPI. Similarly, the 
additional triplicates of run ten had upper-phase and lower-phase AG concentrations of 15.4 wt% 
and 13.8 wt%, respectively, which contradicts the phase equilibrium-predictions of Christian, et al. 
(1998).  Hence further work is needed to accurately determine the concentration of AG and WPI in a 
PEG-AG extractive system. 
 
 
Figure 5. Standard curve of absorbance at 280 nm against WPI concentration (mg/ml) 
 
Table 8. Absorbance measurements and upper phase arabinogalactan and protein concentrations for AG-PEG 
two-phase aqueous extraction systems at a reduced protein dose. 
 
Run Absorbance 
(280 nm) 
Absorbance 
(320 nm) 
Dilution 
Factor 
Upper Phase AG 
Concentration 
(wt %) 
Upper Phase Protein 
Concentration (mg/ml) 
10 1.044 0.491 0.01 20.7(3) 0.02(2) 
11 0.940 0.430 0.01 18.1(5) 0.04(4) 
12 0.939 0.433 0.01 18.2(4) 0.04(3) 
 
Table 9. Volume ratios for high performing AG-PEG two-phase aqueous extraction systems at a reduced 
protein dose. 
Run  Upper Phase Volume (mL) Lower Phase Volume (mL) Total System Volume (mL) 
10 6.0 3.5 9.5 
11 5.8 3.5 9.3 
12 5.9 3.5 9.4 
 
Table 10. Protein recovery parameters for high performing AG-PEG two-phase aqueous-extraction systems at 
a reduced protein dose. 
Run  Total WPI in 
System (mg) 
WPI in Upper 
Phase (mg) 
Upper Phase WPI 
Recovery (% w/w) 
 Overall WPI Partition 
Coefficient (Kp) 
10 0.000 0.11(13) – – 
11 26.860 0.26(25) 1.0% 0.01 
y = 1.0334x 
R² = 0.982 
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12 13.554 0.21(18) 1.6% 0.02 
 
Fast Protein Liquid Chromatography (FPLC) 
Stacked traces from the FPLC run are shown in Figure 6. A comparison of peaks reveals that α-
lactalbumin (α-lac) is the main protein extracted into the top phase. A small amount of β-
lactoglobulin (β-lac) is present in the sample, but at a much lower concentration than α-lac. This is 
an interesting result, as the FPLC data indicates that the mass ratio of α-lac to β-lac is ca. 8:25, which 
is consistent with Goff (2009). Hence the α-lac has been preferentially extracted into the upper 
phase, although the precise extraction mechanism remains unknown. 
 
 
Figure 6. Stacked FPLC traces for various samples in 10 mM pH 5.4 citrate buffer + 100 mM KCl 
 
The traces also show that AG is responsible for blank samples absorbing 280 nm UV light. PEG does 
not respond to 280 nm light, as its trace does not contain any peaks. 
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Although no definitive quantification was carried out, the AG-PEG-WPI sample appears to contain 
much more AG than α-lac. The ease of separating AG from the α-lac will be an important 
consideration for future studies and the economics of any commercial applications that arise from 
these results. 
 
Conclusions 
A two phase aqueous system containing 17.20% (w/w) arabinogalactan (AG); 7.20% (w/w) 
polyethylene glycol (PEG); 10 mmol/g citrate buffer (pH 5.4); 100.0 mmol/g KCl; and 20 mg/g of 
whey protein isolate (WPI) extracted 60% (w/w) of the WPI to the top phase. The protein extract 
was much richer in α-lactalbumin than the original WPI, indicating that preferential partitioning of 
the whey proteins took place. This makes AG-PEG two-phase aqueous extraction a potentially useful 
method for reducing the use of packed bed chromatography in the downstream processing of 
biopharmaceutical products. However the relatively low concentration of whey protein relative to 
AG means that packed bed chromatography will still be required to separate the two compounds. 
 
Reducing the dose of WPI from 20 mg/g to 10 mg/g improved protein recovery, but the theoretical 
protein recovery exceeded 100%, which is unrealistic. This was likely due to the blank used to zero 
the spectrophotometer. Absorbance correlates linearly with concentration of AG (280 nm and 320 
nm), and WPI (280 nm). However attempts to use a 320 nm to 280 nm absorbance ratio to correct 
280 nm absorbance measurements for AG content yielded unrealistic results. Additionally, the 
arabinogalactan content in the upper phase decreased in the presence of protein. Hence the 60% 
(w/w) protein recovery estimate may be conservative. 
 
Increasing the relative mass of the upper phase appeared to greatly reduce the efficacy of protein 
separation, but the effect of decreasing it remains unknown. Future studies should optimise the pH, 
citrate buffer concentration and KCl concentration using pH 5.4, 10 mmol/g citrate buffer and 100 
mmol/g KCl as a starting point. Future studies should also investigate the discrepancy between 
predicted and actual AG concentration in the upper and lower phases. The effect of chaotropic and 
kosomtropic salts on separation performance should also be investigated. 
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